The nitroxide Tempol modulates anthracycline resistance in breast cancer cells

Free Radical Biology & Medicine
M B GariboldiE Monti

Abstract

The occurrence of multidrug resistance (MDR) is the major obstacle to successful anthracycline-based cancer chemotherapy. In the present study, we assessed the effects of Tempol (4-hydroxy-2,2,6,6-tetramethylpiperidine-N-oxyl, TPL), a piperidine nitroxide with growth-inhibitory properties in tumor cell lines, on a number of molecular mechanisms involved in the resistance of human breast adenocarcinoma cell lines to doxorubicin (DOX). Cytotoxicity studies in MCF-7 wildtype and their MDR variant MCF-7 Adr(R) cells showed a synergistic effect between TPL and DOX when exposure to TPL preceded or was simultaneous with DOX treatment in MCF-7 Adr(R) cells. This effect of TPL seems to be due in part to its ability to increase peroxide levels and to deplete cellular glutathione pools. In addition, TPL increased DOX accumulation in MCF-7 Adr(R) cells by interfering with P-glycoprotein-mediated DOX efflux, as evidenced using a specific antibody that recognizes the active form of the protein. TPL was also found to affect the expression levels of proteins involved in response to drug treatment (e.g., p53, bcl2, bax, p21). Taken together, our results indicate that TPL is a potential new agent that may improve the clinical effect of DOX in tu...Continue Reading

References

Jun 15, 1992·Proceedings of the National Academy of Sciences of the United States of America·M C KrishnaA Russo
Aug 15, 1991·Archives of Biochemistry and Biophysics·J B MitchellA Russo
Aug 15, 1995·Proceedings of the National Academy of Sciences of the United States of America·G J ZamanP Borst
Jan 1, 1996·Free Radical Biology & Medicine·E MontiC Oliva
Mar 1, 1996·General Pharmacology·D NielsenT Skovsgaard
Jan 1, 1997·Free Radical Biology & Medicine·S M HahnJ B Mitchell
Dec 16, 1997·Proceedings of the National Academy of Sciences of the United States of America·E B MechetnerI B Roninson
Aug 15, 1998·Biochemical and Biophysical Research Communications·M J MeredithM L Freeman
Apr 15, 1999·European Journal of Clinical Investigation·A G Hall
Mar 10, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Z BenderraM Manfait
Aug 31, 2001·Journal of Cellular Biochemistry·E MontiM B Gariboldi
Jan 31, 2002·Annual Review of Medicine·Michael M Gottesman
May 11, 2002·Nature Reviews. Cancer·Frederik H Igney, Peter H Krammer
Jul 26, 2002·The Journal of Biological Chemistry·Qun WuSuxing Liu
Oct 25, 2003·Oncogene·Tito Fojo, Susan Bates
May 8, 2004·Antioxidants & Redox Signaling·Yuval SamuniJames B Mitchell
Jun 24, 2004·Human Molecular Genetics·Ralf SchubertAnthony Wynshaw-Boris
Jan 11, 2005·The Journal of Pathology·D B Longley, P G Johnston
Apr 20, 2005·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Olivier MeuretteMarie-Thérèse Dimanche-Boitrel
May 13, 2005·Human Molecular Genetics·Laura ErkerAnthony Wynshaw-Boris

❮ Previous
Next ❯

Citations

Jul 1, 1995·Free Radical Biology & Medicine·G Cilento, W Adam
Mar 21, 2012·Cancer Research·Gang ChengBalaraman Kalyanaraman
Jul 22, 2015·Breast Cancer : the Journal of the Japanese Breast Cancer Society·Eric BadiaJean Paul Cristol
Mar 4, 2008·Free Radical Biology & Medicine·Edlaine LinaresOhara Augusto
Dec 29, 2007·Arteriosclerosis, Thrombosis, and Vascular Biology·Marcel LibermanFrancisco R M Laurindo
Jun 16, 2009·Free Radical Research·Vasily I KaledinIgor A Grigor'ev
Nov 8, 2020·Molecules : a Journal of Synthetic Chemistry and Natural Product Chemistry·Jan CzepasKrzysztof Gwoździński

❮ Previous
Next ❯

Related Concepts

Related Feeds

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Related Papers

European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
M B GariboldiE Monti
Free Radical Biology & Medicine
Benjamin P SouleJames B Mitchell
© 2022 Meta ULC. All rights reserved